|Mr. Murray S. Kessler||CEO, Pres & Director||3.06M||N/A||1960|
|Mr. Raymond P. Silcock||CFO, Principal Accounting Officer & Exec. VP||1.48M||N/A||1951|
|Mr. James E. Dillard III||Exec. VP & Chief Scientific Officer||1.01M||N/A||1964|
|Mr. Jeffrey R. Needham||Exec. Officer||1.11M||N/A||1956|
|Mr. Svend Andersen||Exec. VP & Pres of Consumer Healthcare International||1.08M||N/A||1962|
Perrigo Company plc manufactures and supplies over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. It provides upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Steripod, and Rembrandt brand names. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force. Perrigo Co. plc has a partnership with NetworkWire to license Witi's patent-pending hardware and software IP in development of a smoking cessation product. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Perrigo Company plc’s ISS Governance QualityScore as of December 8, 2019 is 5. The pillar scores are Audit: 3; Board: 8; Shareholder Rights: 4; Compensation: 6.